Information Provided By: 
Fly News Breaks for November 11, 2015
SPLK
Nov 11, 2015 | 07:07 EDT
William Blair analyst Bhavan Suri views Splunk's risk/reward as favorable into the company's Q3 results on November 19. The consensus revenue forecast could prove conservative, Suri tells investors in a research note. The analyst also expects Splunk to issue above consensus guidance for Q4 and keeps an Outperform rating on the stock.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
